Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Company: Metrion Biosciences
Location: Granta Park, Cambridge, UK
Contract: Permanent, full-time
About Metrion
Metrion Biosciences (‘Metrion’) is a UK-based, ion channel focused Contract Research Organisation (CRO) providing high-quality in vitro preclinical drug discovery and safety profiling services. From our headquarters at Granta Park, Cambridge, we support a global customer base with cardiac safety profiling, ion channel drug discovery screening, medicinal chemistry screening support, and neuroscience assay services.
By Monalisa Breazu, Learning & Development Administrator
We recently hosted a seminar on business lead generation from events that sparked a lot of honest conversation around something many businesses know all too well: being busy is not always the same as generating real opportunities.
Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time.
The Cambridge-Oxford-London corridor is widely regarded as one of the most productive life sciences clusters in the world, home to hundreds of biotechnology companies, globally recognised research institutions and a rapidly expanding venture capital ecosystem.
Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time.
The Cambridge-Oxford-London corridor is widely regarded as one of the most productive life sciences clusters in the world, home to hundreds of biotechnology companies, globally recognised research institutions and a rapidly expanding venture capital ecosystem.
Pharmaron is a global CRO helping pharma and biotech companies bring new therapies to life. With over 25,000 employees worldwide across our sites in the UK, US, and China, we support drug discovery through to manufacturing with fully integrated, high‑quality R&D services.
We're proud of the impact we make—supporting hundreds of discovery projects, CMC programmes, and clinical trials each year. Our teams work across a wide range of therapeutic modalities, from small molecules to advanced biologics and gene therapies, partnering with more than 3,000 customers globally.
by Philippa Clark, Director of Business Development, One Nucleus
I recently attended a women‑led science event, and it’s one of those occasions that stays with you for reasons you don’t fully expect. It wasn’t a single presentation or statistic that caught my attention, but a theme that kept resurfacing throughout the day and gradually shifted how I was thinking about the whole topic.
Breakthroughs are accelerating across therapeutics, data platforms, regulatory systems and business models. Yet challenges remain in how we develop and scale innovation within an increasingly complex landscape. Addressing these challenges requires collaboration across the life science ecosystem.
by Philippa Clark, Director of Business Development, One Nucleus